KZR
Kezar Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.29
+0.00%Latest reported
- Last report date
- May 11, 2026
- EPS actual
- -$0.78
- EPS estimate
- -$0.98
- Revenue actual
- —
- Revenue estimate
- $1.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -0.8%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 11, 2026 | -$0.98 | -$0.78 | Beat 20.41% | — |
| Mar 31, 2026 | -$1.31 | -$1.99 | Miss -51.98% | — |
| Nov 12, 2025 | -$1.81 | -$1.53 | Beat 15.47% | — |
| Aug 13, 2025 | -$2.15 | -$1.87 | Beat 13.02% | — |
| Mar 25, 2025 | -$2.71 | -$2.77 | Miss -2.21% | — |
| May 9, 2024 | -$3.40 | -$3.00 | Beat 11.76% | — |
| Mar 14, 2024 | -$3.90 | -$3.50 | Beat 10.26% | -$5.4M |
| Nov 13, 2023 | -$3.60 | -$3.20 | Beat 11.11% | $7.0M |
| Aug 10, 2023 | -$3.30 | -$3.40 | Miss -3.03% | — |
| May 11, 2023 | -$2.80 | -$3.10 | Miss -10.71% | — |
| Mar 14, 2023 | -$2.40 | -$2.50 | Miss -4.17% | — |
| Nov 10, 2022 | -$2.60 | -$2.50 | Beat 3.85% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 6, 2026